安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- List of 43 Hemophilia A Medications Compared - Drugs. com
Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available
- Hemophilia Therapies - Rare Disease Advisor
Koāte ® (antihemophilic factor [human]), also known as Koāte-DVI, is a human plasma-derived FVIII indicated for the treatment and prevention of bleeding episodes in patients with hemophilia A Initially approved in the US in 1974, the processing methods have been updated over the years to make the product safer from viral contamination
- Our Treatments | Sanofi Rare Blood Disorders
ALTUVIIIO ® [antihemophilic factor (recombinant), Fc‑VWF‑XTEN fusion protein‑ehtl] is an injectable medicine that is used to control and reduce the number of bleeding episodes in people with hemophilia A (congenital Factor VIII deficiency)
|
|
|